Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

U.S. patent issues for bone substitute technology

Aug. 5, 1997

Insulin mediator isolated from beef liver

Aug. 5, 1997

Alteon's pimagedine progresses to phase III

Aug. 4, 1997

Crinone approved in U.S. for additional indication

Aug. 4, 1997

Ergoset improves metabolism in healthy obese women

Aug. 4, 1997

Novartis reports new NPY antagonists with selectivity for Y5 receptors

Aug. 1, 1997

Clinical trial of Lipitor for the reduction of cholesterol in women

July 31, 1997

Acute and subchronic effects of SR-58611A on glucose tolerance in mice

July 31, 1997

Troglitazone approved in the U.K.

July 31, 1997

Phase I comparison of CCKA agonist and CCK-8 for effects on satiety

July 31, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...